Here’s my selection of fifty stocks that scored highest in my recent screening – for details see below. Briefly, for each stock from NYSE and NASDAQ for areas were assessed: Valuation (V), Profitability (P), Growth (G) and Health (H); then, the overall score (here: Score) was calculated and what you see below is an ordered list of top stocks.

Compare with last week’s listing.

Enjoy and don’t forget to leave a comment! Continue reading “Updated: Fifty stocks with quite strong fundamentals (valuation, profitability, growth, health)”

 

FLGT (FULGENT GENETICS, INC.)
Score: 85.16 out of 100.00

 

Key points:

  • FLGT stock price looks quite attractive compared to its valuation a couple months ago
  • The company has relatively strong fundamentals
  • There are however mixed signals whether it’s a buy or not
  • The biggest concern is that it is considered a “COVID” company; while it’s last year’s profit came largely from COVID-19 testing, the company offers much more than that, including oncology-related genetic testing, with quite considerable investments in that area

 

Profile

Company’s website

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.

Continue reading “Fulgent Genetics (NASDAQ:FLGT): buy or not?”

Here’s my selection of cheap stocks that scored highest in my recent screening – for details see below. Briefly, for each stock from NYSE and NASDAQ for areas were assessed: Valuation (V), Profitability (P), Growth (G) and Health (H); then, the overall score (here: Score) was calculated and what you see below is an ordered list of top stocks.

See also my list of top scoring stocks and stocks with poor fundamentals.

Enjoy and don’t forget to leave a comment!

Continue reading “Top cheap stocks, based on their valuation, profitability, growth and overall health”

Here’s my selection of dividend stocks that scored highest in my recent screening – for details see below. Briefly, for each stock from NYSE and NASDAQ for areas were assessed: Valuation (V), Profitability (P), Growth (G) and Health (H); then, the overall score (here: Score) was calculated and what you see below is an ordered list of top stocks.

Div yield: dividend yield.

See also my list of top scoring stocks and stocks with poor fundamentals.

Enjoy and don’t forget to leave a comment!

Continue reading “Top dividend stocks, based on their valuation, profitability, growth and overall health”

Here’s my selection of fifty stocks that scored lowest in my screening – for details see below. Briefly, for each stock from NYSE and NASDAQ for areas were assessed: Valuation (V), Profitability (P), Growth (G) and Health (H); then, the overall score (here: Score) was calculated and what you see below is an ordered list of worst scoring stocks.

A listing of top 50 stocks is available there.

Enjoy and don’t forget to leave a comment! Continue reading “Fifty stocks with quite poor fundamentals”

Here’s my selection of fifty stocks that scored highest in my recent screening – for details see below. Briefly, for each stock from NYSE and NASDAQ for areas were assessed: Valuation (V), Profitability (P), Growth (G) and Health (H); then, the overall score (here: Score) was calculated and what you see below is an ordered list of top stocks.

Compare with last week’s listing.

Enjoy and don’t forget to leave a comment! Continue reading “Fifty stocks with relatively strong fundamentals: Aug 26th”

Here’s my selection of fifty stocks that scored lowest in my screening – for details see below. Briefly, for each stock from NYSE and NASDAQ for areas were assessed: Valuation (V), Profitability (P), Growth (G) and Health (H); then, the overall score (here: Score) was calculated and what you see below is an ordered list of worst scoring stocks.

A listing of top 50 stocks is available there.

Enjoy and don’t forget to leave a comment! Continue reading “Fifty stocks with poor fundamentals you would rather avoid”

Here’s my selection of fifty stocks that scored highest in my screening – for details see below. Briefly, for each stock from NYSE and NASDAQ for areas were assessed: Valuation (V), Profitability (P), Growth (G) and Health (H); then, the overall score (here: Score) was calculated and what you see below is an ordered list of top stocks.

A more detailed analysis of the top stock (CODX) is available here.

You can also look up the poorest scoring stocks there.

Enjoy and don’t forget to leave a comment!

Continue reading “Fifty stocks with relatively strong fundamentals”

CODX (CO-DIAGNOSTICS, INC.)
Score: 89.39 out of 100.00*

 

* My scoring formula, for details see below.

 

Key points:

  • Co-Diagnostics Inc scores highest in industry (Biotechnology), taking into account its valuation, profitability, growth and health.
  • 89.39 also represents one of the best scores out of 4969 companies screened
  • Based on infromation from news outlets, social media and analysts recommendations, CODX is overall viewed as a valuable stock
  • In my opinion, relatively strong fundamentals and position in the market make this small company a reasonable candidate for further research and a potential mid-term investment (min. 6 months)

Profile

Company’s website

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Continue reading “Co-Diagnostics Inc (CODX): why I find the stock attractive”

Here is a couple of stocks that might be worth your attention this week. This is part 2 of 2. To read the first listing, please go to Part 1.

This short list was compiled with help of various sources of data, including Buy recommendations from several renowned stock data providers and analytical services. This is why I’m calling the approach a consensus strategy. The stocks I’m going to present you below are generally believed to outperform the stock market in the coming months, they have a consensus recommendation of Buy, their fundamentals are scored considerably better than most stocks and their average target price by stock analysts is above current market valuation.

In order to consider buying the stock’s shares, the following criteria need to be satisfied:

  • TheStreet score: A+, A or A-
  • Zacks Rank: 1 (Strong Buy), 2 (Buy) or 3 (Hold)
  • Weiss Ratings recommendation: A or B
  • Yahoo Finance recommendation: at least mixed Buy/Hold
  • MarketBeat recommendation: at least mixed Buy/Hold
  • Yahoo Finance target price: min. 5% higher than current price
  • MarketBeat target price: min. 5% higher than current price
  • Piotroski F-Score: min. 4
  • Moody’s Daily Credit Risk: 1 to 6
  • InvestorsObserver Overall Score: min. 50
Note: Descriptions of those criteria are provided at the end of this post as well as HERE.